In stark contrast, OT1 cells undergoing LSD1 depletion during the IL-2 expansion phase post-TCR stimulation (4-OHT treatment during day 2–4) did not impact tumor growth, similar to cells retaining LSD1 function (no 4-OHT treatment) (Fig. 5l). The gene discussed is IL2; the disease is neoplasm.